University of California, San Francisco, 3333 California St, Ste 420, Box 0613, San Francisco, CA 94143-0613, USA.
Am J Manag Care. 2013 Feb 1;19(2):e38-45.
To calculate the costs associated with implementing and operating an inpatient bar-code medication administration (BCMA) system in the community hospital setting and to estimate the cost per harmful error prevented.
This is a retrospective, observational study. Costs were calculated from the hospital perspective and a cost-consequence analysis was performed to estimate the cost per preventable adverse drug event averted.
Costs were collected from financial records and key informant interviews at 4 not-for profit community hospitals. Costs included direct expenditures on capital, infrastructure, additional personnel, and the opportunity costs of time for existing personnel working on the project. The number of adverse drug events prevented using BCMA was estimated by multiplying the number of doses administered using BCMA by the rate of harmful errors prevented by interventions in response to system warnings. Our previous work found that BCMA identified and intercepted medication errors in 1.1% of doses administered, 9% of which potentially could have resulted in lasting harm.
The cost of implementing and operating BCMA including electronic pharmacy management and drug repackaging over 5 years is $40,000 (range: $35,600 to $54,600) per BCMA-enabled bed and $2000 (range: $1800 to $2600) per harmful error prevented.
BCMA can be an effective and potentially cost-saving tool for preventing the harm and costs associated with medication errors.
计算在社区医院环境中实施和运营住院条码药物管理(BCMA)系统所涉及的成本,并估算每预防一次有害错误所节省的成本。
这是一项回顾性观察性研究。成本从医院角度进行计算,并进行成本后果分析,以估算每避免一次可预防的药物不良事件所节省的成本。
从 4 家非营利性社区医院的财务记录和关键知情者访谈中收集成本数据。成本包括资本、基础设施、额外人员的直接支出,以及参与项目的现有人员的时间机会成本。使用 BCMA 预防的不良药物事件数量通过将使用 BCMA 管理的剂量乘以对系统警报做出反应的干预措施预防的有害错误率来估算。我们之前的工作发现,BCMA 在 1.1%的给药剂量中识别和拦截了药物错误,其中 9%可能导致持久伤害。
实施和运营 BCMA(包括电子药房管理和药品重新包装)5 年的总成本为每台 BCMA 启用床位 40,000 美元(范围:35,600 美元至 54,600 美元),每预防一次有害错误 2000 美元(范围:1800 美元至 2600 美元)。
BCMA 可以是一种有效且可能具有成本效益的工具,可用于预防与药物错误相关的伤害和成本。